Valuation: Byotrol plc

Market Cap 194K 261K 228K 211K 367K 25.17M 373K 2.52M 989K 12.29M 981K 959K 42.43M P/E 2023
-2.12x
P/E 2024 -0.06x
Enterprise Value 845K 1.14M 995K 921K 1.6M 110M 1.63M 10.98M 4.31M 53.59M 4.28M 4.18M 185M EV / Sales 2023
0.84x
EV / Sales 2024 0.21x
Free-Float
24.18%
Yield 2023 *
-
Yield 2024 -
Manager TitleAgeSince
Chief Executive Officer 50 30/06/2024
Director TitleAgeSince
Director/Board Member 50 12/12/2021
Chairman 75 21/04/2024
Change 5-day change 1-year change 3-year change Capi.($)
-20.00%-20.00% - - 247K
+2.33%+3.17%-1.45%+0.97% 353B
+0.65%+1.54%-6.34%+3.27% 134B
+2.84%+3.36%+7.31%+23.06% 75.27B
+2.16%-0.32%-14.58%-20.06% 51.17B
+1.71%-0.83%-12.95%-23.74% 36.52B
+0.64%+1.04%-4.12%-57.22% 29.97B
+0.18%+2.98%-25.52%-31.03% 19.99B
+3.53%+1.37%+13.82%-0.42% 19.11B
+0.70%+2.76%-0.81%+27.48% 18.29B
Average -0.71%+0.97%-4.96%-8.63% 81.95B
Weighted average by Cap. +1.04%+2.10%-3.28%-1.65%

Financials

2023 2024
Net sales 4.59M 6.19M 5.41M 5M 8.69M 597M 8.84M 59.68M 23.44M 291M 23.25M 22.74M 1.01B 3.97M 5.35M 4.68M 4.33M 7.51M 516M 7.64M 51.6M 20.27M 252M 20.1M 19.66M 869M
Net income -1.69M -2.28M -1.99M -1.84M -3.2M -220M -3.26M -21.99M -8.64M -107M -8.57M -8.38M -371M -3.06M -4.13M -3.61M -3.34M -5.8M -398M -5.9M -39.82M -15.64M -194M -15.51M -15.17M -671M
Net Debt 287K 387K 338K 313K 543K 37.28M 553K 3.73M 1.47M 18.21M 1.45M 1.42M 62.86M 651K 878K 767K 709K 1.23M 84.57M 1.25M 8.46M 3.32M 41.3M 3.3M 3.22M 143M
Logo Byotrol plc
Byotrol Plc is a United Kingdom-based specialist infection prevention and control company. The Company operates globally in the animal and human healthcare, industrial, institutional and consumer sectors, providing low toxicity products with a broad-based and targeted efficacy across all microbial classes; bacteria, viruses (including coronavirus), fungi, molds, mycobacteria and algae. Its products can be used stand-alone or as ingredients within existing products, especially in personal hygiene, domestic and industrial disinfection, odor control, food production and food management. The Company sells products based on its anti-microbial technology to professional and consumer end users and retailers (product sales). In the professional sector, it serves human health, animal health and facilities management. In the consumer sector, it serves household, skin care and pet care. It serves customers in the United Kingdom; Europe, Middle East, and Africa (EMEA) and North America and Asia.
Employees
35